Literature DB >> 3093524

Variation and adaptation of Pseudomonas aeruginosa toxicity to HeLa cells and fibroblasts.

H Müller, C Kettelhack, M Kettelhack, H G Sonntag, G Keilich, R Brossmer, J Richards, V Kinzel, E Bäuerlein, H Pech.   

Abstract

The toxic components of supernatants from Pseudomonas aeruginosa cultures directed against HeLa cells and Staphylococcus aureus were evaluated with the aim of discovering interactions. Supernatants of eight different strains of P. aeruginosa were assayed for cytotoxic activity. All were active against HeLa cells; seven were toxic for S. aureus. On repeated suspension of P. aeruginosa in 0.9% sodium chloride solution, a shift from HeLa cell toxicity to staphylococcal lytic activity occurred along with a change of toxic activity from a high (50,000 +/- 5,000) to a low (8,000 +/- 400) molecular weight (MW) range on gel filtration. Addition of protein to the minimal medium of cultures producing material toxic only for S. aureus reactivated the generation of HeLa cell-toxic material. Cultivation of P. aeruginosa in the presence of HeLa cells and a chloramphenicol supplement produced suppression of the generation of material toxic for S. aureus but facilitated that of HeLa-toxic material of high MW. Adaptation of toxicity against fibroblasts developed only on cocultivation of P. aeruginosa together with S. aureus and in the presence of fibroblasts. Under these conditions a strong lytic activity for S. aureus appeared, even in the presence of chloramphenicol. Chloramphenicol caused the material toxic for fibroblasts to elute at a low MW well separated from that toxic for HeLa cells. In contrast to the high-MW toxic substances, the low-MW material did not induce antibodies after injection into rabbits. This may explain failures of vaccination against P. aeruginosa infection and of serum therapy of homologous sepsis in humans.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3093524      PMCID: PMC268905          DOI: 10.1128/jcm.24.3.317-323.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  53 in total

1.  Inhibition of Pseudomonas aeruginosa pigment formation by chloramphenicol and erythromycin.

Authors:  S S SCHNEIERSON; D AMSTERDAM; E PERLMAN
Journal:  Antibiot Chemother (Northfield)       Date:  1960-01

2.  Enzymatic determination of serum-free fatty acids: a colorimetric method.

Authors:  S Shimizu; Y Tani; H Yamada; M Tabata; T Murachi
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

3.  Exotoxins of Pseudomonas aeruginosa. I. Factors that influence the production of exotoxin A.

Authors:  P V Liu
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

4.  Purification and characterization of a staphylolytic enzyme from Pseudomonas aeruginosa.

Authors:  M E Burke; P A Pattee
Journal:  J Bacteriol       Date:  1967-03       Impact factor: 3.490

5.  Mechanism of the antibiotic action pyocyanine.

Authors:  H M Hassan; I Fridovich
Journal:  J Bacteriol       Date:  1980-01       Impact factor: 3.490

Review 6.  An evaluation of antipseudomonal antimicrobic agents.

Authors:  D N Gilbert
Journal:  Antibiot Chemother (1971)       Date:  1985

7.  [The identification of nonfermentative gram-negative bacteria. Experiences with 676 apyocyaninogenic strains (author's transl)].

Authors:  U Berger; H D Piotrowski
Journal:  Zentralbl Bakteriol A       Date:  1981-02

8.  [Exotoxins of Pseudomonas aeruginosa. I. Communication: isolation, purification and biochemical analysis].

Authors:  G Keilich; R Brossmer; T Ehrhardt; H Pech; H Müller; H G Sonntag; H Spring; V Kinzel
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol       Date:  1982-05

9.  Mechanism of protein excretion by gram-negative bacteria: Pseudomonas aeruginosa exotoxin A.

Authors:  S Lory; P C Tai; B D Davis
Journal:  J Bacteriol       Date:  1983-11       Impact factor: 3.476

10.  Protection against experimental Pseudomonas aeruginosa infection in mice by active immunization with exotoxin A toxoids.

Authors:  O R Pavlovskis; D C Edman; S H Leppla; B Wretlind; L R Lewis; K E Martin
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.609

View more
  2 in total

1.  In situ survival of plasmid-bearing and plasmidless Pseudomonas aeruginosa in pristine tropical waters.

Authors:  N E Cruz-Cruz; G A Toranzos; D G Ahearn; T C Hazen
Journal:  Appl Environ Microbiol       Date:  1988-10       Impact factor: 4.792

2.  Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis.

Authors:  A E Hollsing; M Granström; M L Vasil; B Wretlind; B Strandvik
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 11.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.